Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

BACKGROUND & AIMS: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces but does not eliminate the risk for hepatocellular carcinoma (HCC). The development of surveillance strategies for HCC after the sustained virologic response (SVR) is therefore warranted. We aimed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JHEP Rep
Autors principals: Dajti, Elton, Marasco, Giovanni, Ravaioli, Federico, Colecchia, Luigi, Ferrarese, Alberto, Festi, Davide, Colecchia, Antonio
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165428/
https://ncbi.nlm.nih.gov/pubmed/34095798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2021.100289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars